Literature DB >> 18054883

Running an ethical trial 60 years after the Nuremberg Code.

Jonathan R Markman1, Maurie Markman2.   

Abstract

The Nuremberg Code has served as a foundation for ethical clinical research since its publication 60 years ago. This landmark document, developed in response to the horrors of human experimentation done by Nazi physicians and investigators, focused crucial attention on the fundamental rights of research participants and on the responsibilities of investigators. Although the Nuremberg Code has provided an important framework for discussions on the requirements of ethical clinical research, and has resulted in the development of other initiatives-eg, the Declaration of Helsinki and the Belmont Report-designed to ensure the rights and safety of human beings taking part in medical research, knowledge of both past events and the current complexity of research suggests further improvements are necessary in the existing approaches to human clinical research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054883     DOI: 10.1016/S1470-2045(07)70381-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  6 in total

Review 1.  The collaborative autonomy model of medical decision-making.

Authors:  Michael A Rubin
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

Review 2.  Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

Review 3.  Hippocratic oath and conversion of ethico-regulatory aspects onto doctors as a physician, private individual and a clinical investigator.

Authors:  Mohammed Imran; Shadab Samad; Mohammad Maaz; Ashhar Qadeer; Abul Kalam Najmi; Mohammed Aqil
Journal:  J Midlife Health       Date:  2013-10

4.  Phosphoethanolamine and the danger of unproven drugs.

Authors:  Noam Pondé; Evandro de Azambuja; Felipe Ades
Journal:  Ecancermedicalscience       Date:  2016-10-17

5.  Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China.

Authors:  Y Shen; X Peng; M Wang; X Zheng; G Xu; L Lü; K Xu; B Burstrom; K Burstrom; J Wang
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

6.  The evolution of withdrawal: negotiating research relationships in biobanking.

Authors:  Karen Melham; Linda Briceno Moraia; Colin Mitchell; Michael Morrison; Harriet Teare; Jane Kaye
Journal:  Life Sci Soc Policy       Date:  2014-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.